One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

Researchers developed a DNA-scaffolded vaccine that achieves the first step in generating a significant population of B cells that produce broadly neutralizing antibodies against HIV.

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In ...

Harvard scientists' protein-based scaffold grown on a polymer substrate could be used to grow organ tissue and treat wounds. Researchers in the School of Engineering and Applied Science at Harvard ...

Tissues are where most biological functions, drug effects and diseases occur, and are often considered a homogenous entity where different types of cells are woven in regularly repeated patterns.

Forget the standard guidelines—as you age, your body’s demand for high-quality protein skyrockets to prevent muscle wasting ...